LightPath Technologies, Inc. (NASDAQ:LPTH) Q1 2021 Earnings Conference Call November 5, 2020 4:30 PM ET Company Participants Donald Retreage - Chief Financial Officer Sam Rubin - President and Chief Executive Officer Conference Call Participants Brian Kinstlinger - Alliance Global Partners Gene Inger - The Inger Letter Operator Good afternoon and welcome to the LightPath Technologies Fiscal 2021 First Quarter Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instruct ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ____________ Commission file number 000-27548 LIGHTPATH TECHNOLOGIES, INC. ___________________________________________________ (Exact name of ...

Ligh LOGIES INVESTOR PRESENTATION SEPTEMBER 23, 2020 GLOBAL LEADER IN OPTICAL TECHNOLOGY 2 Safe Harbor Statement This presentation contains "forward-looking" statements that are based on our beliefs and assumptions and on information currently available to us. Forward-looking statements include information concerning our possible or assumed future results of operations, business strategies, product development plans, competitive position, potential growth opportunities, the effects of competition and the ex ...

LightPath Technologies, Inc. (NASDAQ:LPTH) Q4 2020 Results Earnings Conference Call September 10, 2020 4:30 PM ET Company Participants Sam Rubin - President and Chief Executive Officer Donald Retreage - Chief Financial Officer Conference Call Participants Marc Wiesenberger - B. Riley FBR Gene Inger - ingerletter.com Operator Good afternoon, and welcome to the LightPath Technologies Fiscal Fourth Quarter and Year-End 2020 Financial Results Conference Call. All participants will be in a listen-only mode. [Ope ...

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) For the fiscal year ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-27548 LIGHTPATH TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation o ...

OLOGIES INVESTOR PRESENTATION SEPTEMBER 2020 GLOBAL LEADER IN OPTICAL TECHNOLOGY 2 Safe Harbor Statement This presentation contains "forward-looking" statements that are based on our beliefs and assumptions and on information currently available to us. Forward-looking statements include information concerning our possible or assumed future results of operations, business strategies, product development plans, competitive position, potential growth opportunities, the effects of competition and the expected e ...

LightPath Technologies, Inc. (NASDAQ:LPTH) Q3 2020 Earnings Conference Call May 7, 2020 4:30 PM ET Company Participants Donald Retreage - Chief Financial Officer Sam Rubin - President and Chief Executive Officer Conference Call Participants Marc Wiesenberger - B. Riley Operator Good afternoon, and welcome to the LightPath Technologies Third Quarter 2020 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please also note today’s event is being recorded. ...

[Cautionary Note Concerning Forward-Looking Statements](index=4&type=section&id=Cautionary%20Note%20Concerning%20Forward-Looking%20Statements) This report contains forward-looking statements subject to numerous risks and uncertainties beyond the company's control - This report contains forward-looking statements based on current expectations and assumptions. These statements are subject to numerous risks and uncertainties, many of which are beyond the company's control[11](index=11&type=chunk) - Key risks highlighted include the duration and scope of the COVID-19 pandemic, its impact on product demand and supply chains, government and individual responses to the pandemic, and general economic uncertainty[11](index=11&type=chunk) [Part I Financial Information](index=5&type=section&id=Part%20I%20Financial%20Information) [Financial Statements](index=5&type=section&id=Item%201%20Financial%20Statements) The unaudited condensed consolidated financial statements for the period ended March 31, 2020, reflect improved financial performance and asset growth [Unaudited Condensed Consolidated Balance Sheets](index=5&type=section&id=Unaudited%20Condensed%20Consolidated%20Balance%20Sheets) The balance sheet as of March 31, 2020, shows increased total assets and stockholders' equity, with decreased liabilities Condensed Consolidated Balance Sheet Highlights (unaudited) | Balance Sheet Item | March 31, 2020 ($ million) | June 30, 2019 ($ million) | | :--- | :--- | :--- | | **Total Current Assets** | $19.80 | $19.61 | | **Total Assets** | $46.06 | $45.97 | | **Total Current Liabilities** | $6.14 | $6.36 | | **Total Liabilities** | $12.14 | $12.51 | | **Total Stockholders' Equity** | $33.91 | $33.46 | [Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss)](index=6&type=section&id=Unaudited%20Condensed%20Consolidated%20Statements%20of%20Comprehensive%20Income%20(Loss)) For Q3 2020, revenue increased **10%** to **$8.7 million**, with net income of **$0.82 million**, reversing a prior-year loss Financial Performance Summary (unaudited) | Metric | Q3 2020 ($) | Q3 2019 ($) | Nine Months 2020 ($) | Nine Months 2019 ($) | | :--- | :--- | :--- | :--- | :--- | | **Revenue, net** | $8,708,981 | $7,905,582 | $25,860,823 | $25,003,810 | | **Gross Margin** | $4,012,176 | $3,105,669 | $10,332,274 | $9,689,985 | | **Operating Income (Loss)** | $1,062,812 | $20,818 | $1,507,366 | $(63,252) | | **Net Income (Loss)** | $816,017 | $(352,018) | $209,977 | $(918,633) | | **EPS (diluted)** | $0.03 | $(0.01) | $0.01 | $(0.04) | [Unaudited Condensed Consolidated Statement of Changes in Stockholders' Equity](index=7&type=section&id=Unaudited%20Condensed%20Consolidated%20Statement%20of%20Changes%20in%20Stockholders'%20Equity) Total stockholders' equity increased from **$33.5 million** to **$33.9 million**, primarily due to net income and stock-based compensation - Stockholders' equity rose to **$33.91 million** at March 31, 2020, from **$33.46 million** at June 30, 2019[19](index=19&type=chunk) - The change was primarily due to net income of **$0.21 million** for the nine months ended March 31, 2020, and stock-based compensation of **$0.29 million**[19](index=19&type=chunk) [Unaudited Condensed Consolidated Statements of Cash Flows](index=8&type=section&id=Unaudited%20Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) For the nine months ended March 31, 2020, net cash from operations was **$1.9 million**, a significant improvement, while investing and financing activities used cash Cash Flow Summary (Nine Months Ended March 31) | Cash Flow Activity | 2020 ($) | 2019 ($) | | :--- | :--- | :--- | | **Net cash provided by operating activities** | $1,869,783 | $25,947 | | **Net cash used in investing activities** | $(1,318,035) | $(1,356,732) | | **Net cash used in financing activities** | $(727,039) | $(1,154,048) | | **Change in cash and cash equivalents** | $(222,988) | $(1,867,163) | | **Cash and cash equivalents, end of period** | $4,381,713 | $4,641,457 | [Notes to Unaudited Condensed Consolidated Financial Statements](index=9&type=section&id=Notes%20to%20Unaudited%20Condensed%20Consolidated%20Financial%20Statements) The notes detail accounting policies, including ASC Topic 842 adoption, revenue breakdown by product group, debt structure, and foreign cash holdings - The company adopted lease accounting standard ASC Topic 842 on July 1, 2019, recognizing operating lease right-of-use assets of **$1.7 million** and corresponding operating lease liabilities of **$2.3 million**[28](index=28&type=chunk) Revenue by Product Group (Nine Months Ended March 31) | Product Group | 2020 ($ million) | 2019 ($ million) | | :--- | :--- | :--- | | PMO | $10.75 | $10.59 | | Infrared Products | $13.26 | $12.52 | | Specialty Products | $1.85 | $1.89 | | **Total revenue** | **$25.86** | **$25.00** | - In December 2019, the company declared and paid a **$2 million** intercompany dividend from its Chinese subsidiary LPOIZ, resulting in **$0.2 million** of accrued Chinese withholding taxes[45](index=45&type=chunk) - As of March 31, 2020, the company was in compliance with all covenants for its BankUnited loans, including a term loan, revolving line of credit, and guidance line[71](index=71&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=21&type=section&id=Item%202%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses the company's financial performance, highlighting a **10%** revenue increase in Q3 2020 to **$8.7 million**, improved gross margin, and a net income of **$0.82 million** [Overview](index=21&type=section&id=Overview) LightPath is a global manufacturer of optical components and assemblies across three product groups, with recent organizational changes to enhance product portfolio management - The company's business is organized into three product groups: **Precision Molded Optics (PMO)**, **infrared products**, and **specialty products**[90](index=90&type=chunk) - Recent organizational changes were designed to better leverage expanded capabilities and manage a broader product portfolio, including a new product management function[89](index=89&type=chunk) [Results of Operations](index=23&type=section&id=Results%20of%20Operations) For Q3 2020, revenue grew **10%** to **$8.7 million**, with gross margin increasing to **46%**, resulting in a net income of **$0.82 million**, a significant turnaround Q3 2020 vs Q3 2019 Performance | Metric | Q3 2020 ($) | Q3 2019 ($) | Change ($) | | :--- | :--- | :--- | :--- | | **Revenue** | $8.7M | $7.9M | +10% | | **Gross Margin** | $4.0M (46%) | $3.1M (39%) | +29% | | **Net Income (Loss)** | $816K | $(352K) | +$1.17M | - The increase in Q3 PMO revenue was driven by sales to medical and telecommunications markets, while infrared revenue growth was fueled by molded products for applications like fever detection[95](index=95&type=chunk) - For the nine months ended March 31, 2020, net income was **$0.21 million**, compared to a net loss of **$0.92 million** in the prior-year period, primarily due to a **$1.6 million** improvement in operating income[111](index=111&type=chunk) [Liquidity and Capital Resources](index=26&type=section&id=Liquidity%20and%20Capital%20Resources) As of March 31, 2020, the company had working capital of **$13.7 million** and cash of **$4.4 million**, with **$1.9 million** in cash flow from operations - At March 31, 2020, working capital was **$13.7 million** and cash and cash equivalents were **$4.4 million**[113](index=113&type=chunk) - Cash flow from operations was approximately **$1.9 million** for the first nine months of fiscal 2020, compared to only **$26K** for the same period in fiscal 2019[119](index=119&type=chunk) - Capital expenditures for the nine-month period were **$1.5 million**, mainly for expanding BD6 material production and infrared coating capacity[120](index=120&type=chunk) [Sales Backlog](index=28&type=section&id=Sales%20Backlog) The 12-month sales backlog as of March 31, 2020, increased **17%** year-over-year to **$20.0 million**, driven by new orders and contract renewals 12-Month Sales Backlog Trend | Quarter | Backlog ($ K) | Change From Prior Quarter End | | :--- | :--- | :--- | | Q3 2019 | $17,137 | -6% | | Q4 2019 | $17,121 | 0% | | Q1 2020 | $15,390 | -10% | | Q2 2020 | $19,095 | +24% | | Q3 2020 | $20,012 | +5% | - The 12-month backlog at March 31, 2020 was approximately **$20.0 million**, a **17%** increase compared to March 31, 2019[133](index=133&type=chunk) [Non-GAAP Financial Measures](index=31&type=section&id=Non-GAAP%20Financial%20Measures) The company uses EBITDA as a non-GAAP measure, with Q3 2020 EBITDA at **$1.9 million**, more than double the prior year, reflecting improved operating performance EBITDA Reconciliation (unaudited) | Metric | Q3 2020 ($) | Q3 2019 ($) | Nine Months 2020 ($) | Nine Months 2019 ($) | | :--- | :--- | :--- | :--- | :--- | | **Net income (loss)** | $816,017 | $(352,018) | $209,977 | $(918,633) | | **Depreciation & Amortization** | $827,095 | $857,287 | $2,587,315 | $2,540,963 | | **Income tax provision (benefit)** | $203,369 | $161,870 | $673,556 | $(40,493) | | **Interest expense** | $85,464 | $275,233 | $273,262 | $573,535 | | **EBITDA** | **$1,931,945** | **$942,372** | **$3,744,110** | **$2,155,372** | [Controls and Procedures](index=31&type=section&id=Item%204%20Controls%20and%20Procedures) Management concluded that disclosure controls and procedures were effective as of March 31, 2020, with no material changes to internal controls - The CEO and CFO concluded that disclosure controls and procedures were effective as of March 31, 2020[148](index=148&type=chunk) - No material changes were made to internal control over financial reporting in the quarter, with the company monitoring COVID-19's impact on controls[149](index=149&type=chunk) [Part II Other Information](index=32&type=section&id=Part%20II%20Other%20Information) [Legal Proceedings](index=32&type=section&id=Item%201%20Legal%20Proceedings) The company reported no legal proceedings during the period - No legal proceedings were reported[150](index=150&type=chunk) [Risk Factors](index=32&type=section&id=Item%201A.%20Risk%20Factors) No material changes to risk factors were reported, except for a new risk factor concerning the potential adverse effects of pandemics like COVID-19 - A new risk factor was added to address the potential adverse impact of pandemics like **COVID-19**[151](index=151&type=chunk) - The company is considered an "essential business" but acknowledges the pandemic could still materially affect operations, supply chain, and customer demand, with uncertain financial impact[152](index=152&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=32&type=section&id=Item%202%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) During the quarter, **5,000** shares of Class A common stock were issued to a consultant at **$1.23** per share, exempt from registration - Issued **5,000** shares of Class A common stock to a consultant for services, at a price of **$1.23** per share[153](index=153&type=chunk) [Defaults Upon Senior Securities](index=32&type=section&id=Item%203%20Defaults%20Upon%20Senior%20Securities) The company reported no defaults upon senior securities - No defaults upon senior securities were reported[154](index=154&type=chunk) [Exhibits](index=33&type=section&id=Item%206%20Exhibits) This section lists all exhibits filed with the quarterly report, including corporate governance documents and certifications - The exhibits filed with the report include certifications from the CEO and CFO (31.1, 31.2, 32.1, 32.2) and XBRL data files[157](index=157&type=chunk) [Signatures](index=35&type=section&id=Signatures) - The report was duly signed and authorized by **Shmuel Rubin**, President and CEO, and **Donald O. Retreage, Jr.**, CFO, on **May 7, 2020**[159](index=159&type=chunk)[161](index=161&type=chunk)

LightPath Technologies, Inc. (NASDAQ:LPTH) Q2 2020 Results Earnings Conference Call February 6, 2020 4:30 PM ET Company Participants Donald Retreage - Chief Financial Officer Jim Gaynor - President and Chief Executive Officer Conference Call Participants Marc Weissenberg - B Riley FBR Michael Dyett - Private Investor Operator Good afternoon, and welcome to the LightPath Technologies Second Quarter 2020 Financial Results Conference Call. [Operator Instructions] Please also note today’s event is being recorde ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ____________ Commission file number 000-27548 LIGHTPATH TECHNOLOGIES, INC. ------------------------------------------------------------------------ (Exact name of registrant as specified in its ...